Acute Reaction to Influenza Vaccination

Novakova, Silviya; Novakova, Plamena; Staevska, Maria

doi:10.1007/978-3-030-18282-3_25

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study, a significant improvement in the RQLQ score was observed regarding activity limitation, sleep problems, nose symptoms, eye symptoms, practical problems and emotional function. This was in agreement with Novakova et al 17 who reported that immunotherapy with HDM extract significantly increased QoL in patients with allergic rhinitis.…”

Section: Discussionsupporting

confidence: 93%

Effect of Immunotherapy on the Quality of Life in Patients with Allergic Rhinitis Sensitive to House Dust Mite

El-Din

El-Tabakh

Ibrahim

et al. 2019

Egyptian Journal of Medical Microbiology

View full text Add to dashboard Cite

Background: Allergic rhinitis (AR) has serious effects on the quality of life (QoL) of patients. It leads to impairments in daily activities, work and school performance, and practical problems. Objectives: To assessed the effects of HDM immunotherapy on the QoL in patients with AR. Methodology: The QoL was assessed in 120 AR patients sensitive to HDM using Rhinoconjuntivitis Quality of Life Questionnaire (RQLQ). Patients received HDM-specific immunotherapy for 6 months after which the QoL was assessed again. Results: showed that rhinorrhea was the most common symptom (92.5%) while nasal itching was the least (55.8 %). After immunotherapy, a significant number of patients showed improvement of nasal obstruction and rhinorrhea. A significant improvement in the RQLQ score was also observed regarding activity limitation, sleep problems, nose symptoms, eye symptoms, practical problems and emotional function (p < 0.5). Conclusion: HDM immunotherapy improves the QoL in AR patients sensitive to HDM allergens.

show abstract

Section: Discussionsupporting

confidence: 93%